Dangshe MA

Person

Millwood, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-CD8 antibodies and uses thereof
- Patent number 12,077,587
- Issue date Sep 3, 2024
- REGENERON PHARMACEUTICALS, INC.
- Jason T. Giurleo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging
- Patent number 12,053,534
- Issue date Aug 6, 2024
- REGENERON PHARMACEUTICALS, INC.
- Marcus Kelly
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Radiolabeled MET binding proteins for immuno-PET imaging and method...
- Patent number 11,896,682
- Issue date Feb 13, 2024
- REGENERON PHARMACEUTICALS, INC.
- Marcus Kelly
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD8 antibodies and uses thereof
- Patent number 11,525,001
- Issue date Dec 13, 2022
- REGENERON PHARMACEUTICALS, INC.
- Jason T. Giurleo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Radiolabeled anti-LAG3 antibodies for immuno-PET imaging
- Patent number 11,511,001
- Issue date Nov 29, 2022
- REGENERON PHARMACEUTICALS, INC.
- Marcus Kelly
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Radiolabeled anti-LAG3 antibodies for immuno-PET imaging
- Patent number 10,905,784
- Issue date Feb 2, 2021
- REGENERON PHARMACEUTICALS, INC.
- Marcus Kelly
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging
- Patent number 10,736,976
- Issue date Aug 11, 2020
- REGENERON PHARMACEUTICALS, INC.
- Marcus Kelly
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD8 antibodies and uses thereof
- Patent number 10,730,944
- Issue date Aug 4, 2020
- REGENERON PHARMACEUTICALS, INC.
- Jason T. Giurleo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Site specific HER2 antibody drug conjugates
- Patent number 10,689,458
- Issue date Jun 23, 2020
- Pfizer Inc.
- Dangshe Ma
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-IL-13 receptor alpha 2 antibodies and antibody-drug conjugates
- Patent number 9,828,428
- Issue date Nov 28, 2017
- Pfizer Inc.
- Dangshe Ma
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PSMA antibodies and uses thereof
- Patent number 9,695,248
- Issue date Jul 4, 2017
- PSMA Development Company, LLC
- Paul J. Maddon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Alpha emitting constructs and uses thereof
- Patent number 9,289,519
- Issue date Mar 22, 2016
- Sloan-Kettering Institute for Cancer Research
- David A. Scheinberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for killing PSMA-expressing, taxane-resistant cancer cells
- Patent number 9,242,012
- Issue date Jan 26, 2016
- PSMA Development Company, LLC
- Dangshe Ma
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies for the treatment of Clostridium difficile-associated in...
- Patent number 8,986,697
- Issue date Mar 24, 2015
- Progenics Pharmaceuticals, Inc.
- Dangshe Ma
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Alpha-emitting constructs and uses thereof
- Patent number 8,486,409
- Issue date Jul 16, 2013
- Sloan-Kettering Institute for Cancer Research
- David A. Scheinberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PSMA antibodies and uses thereof
- Patent number 8,470,330
- Issue date Jun 25, 2013
- PSMA Development Company, LLC
- Paul J. Maddon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions of PSMA antibodies
- Patent number 8,114,965
- Issue date Feb 14, 2012
- PSMA Development Company, LLC
- Paul J. Maddon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PSMA antibodies and protein multimers
- Patent number 7,850,971
- Issue date Dec 14, 2010
- PSMA Development Company, LLC
- Paul J. Maddon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Alpha emitting constructs and uses thereof
- Patent number 7,736,651
- Issue date Jun 15, 2010
- Sloan-Kettering Institute for Cancer Research
- David Scheinberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted alpha particle therapy using actinium-255 conjugates
- Patent number 6,683,162
- Issue date Jan 27, 2004
- Sloan-Kettering Institute of Cancer Research
- David Scheinberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bismuth-213 generator and uses thereof
- Patent number 6,603,127
- Issue date Aug 5, 2003
- Sloan-Kettering Institute for Cancer Research
- David Scheinberg
- G21 - NUCLEAR PHYSICS NUCLEAR ENGINEERING

Patents Applicationslast 30 patents

Information Patent Application
RADIOLABELED ANTI-PD-L1 ANTIBODIES FOR IMMUNO-PET IMAGING
- Publication number 20240335572
- Publication date Oct 10, 2024
- Regeneron Pharmaceuticals, Inc.
- Marcus Kelly
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RADIOLABELED MET BINDING PROTEINS FOR IMMUNO-PET IMAGING
- Publication number 20240307563
- Publication date Sep 19, 2024
- Regeneron Pharmaceuticals, Inc.
- Marcus Kelly
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RADIOLABELED ANTI-LAG3 ANTIBODIES FOR IMMUNO-PET IMAGING
- Publication number 20230270894
- Publication date Aug 31, 2023
- Regeneron Pharmaceuticals, Inc.
- Marcus Kelly
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD8 ANTIBODIES AND USES THEREOF
- Publication number 20230159639
- Publication date May 25, 2023
- Regeneron Pharmaceuticals, Inc.
- Jason T. Giurleo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RADIOLABELED ANTI-PD-L1 ANTIBODIES FOR IMMUNO-PET IMAGING
- Publication number 20220184241
- Publication date Jun 16, 2022
- Regeneron Pharmaceuticals, Inc.
- Marcus Kelly
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD8 ANTIBODIES AND USES THEREOF
- Publication number 20210147542
- Publication date May 20, 2021
- Regeneron Pharmaceuticals, Inc.
- Jason T. Giurleo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RADIOLABELED ANTI-LAG3 ANTIBODIES FOR IMMUNO-PET IMAGING
- Publication number 20210138096
- Publication date May 13, 2021
- Regeneron Pharmaceuticals, Inc.
- Marcus Kelly
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RADIOLABELED MET BINDING PROTEINS FOR IMMUNO-PET IMAGING
- Publication number 20210077638
- Publication date Mar 18, 2021
- Regeneron Pharmaceuticals, Inc.
- Marcus Kelly
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PSMA ANTIBODY-DRUG CONJUGATES
- Publication number 20210023094
- Publication date Jan 28, 2021
- PSMA Development Company, LLC
- Dangshe Ma
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SITE SPECIFIC HER2 ANTIBODY DRUG CONJUGATES
- Publication number 20200377615
- Publication date Dec 3, 2020
- Pfizer Inc.
- Dangshe MA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RADIOLABELED ANTI-PD-L1 ANTIBODIES FOR IMMUNO-PET IMAGING
- Publication number 20200345872
- Publication date Nov 5, 2020
- Regeneron Pharmaceuticals, Inc.
- Marcus Kelly
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AND ANTIBODY FRAGMENTS FOR SITE-SPECIFIC CONJUGATION
- Publication number 20200069764
- Publication date Mar 5, 2020
- Pfizer Inc.
- Dangshe MA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD8 ANTIBODIES AND USES THEREOF
- Publication number 20190023790
- Publication date Jan 24, 2019
- Regeneron Pharmaceuticals, Inc.
- Jason T. Giurleo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RADIOLABELED ANTI-LAG3 ANTIBODIES FOR IMMUNO-PET IMAGING
- Publication number 20180228926
- Publication date Aug 16, 2018
- Regeneron Pharmaceuticals, Inc.
- Marcus Kelly
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RADIOLABELED ANTI-PD-L1 ANTIBODIES FOR IMMUNO-PET IMAGING
- Publication number 20180161464
- Publication date Jun 14, 2018
- Regeneron Pharmaceuticals, Inc.
- Marcus Kelly
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AND ANTIBODY FRAGMENTS FOR SITE-SPECIFIC CONJUGATION
- Publication number 20170216452
- Publication date Aug 3, 2017
- Pfizer Inc.
- Dangshe MA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SITE SPECIFIC HER2 ANTIBODY DRUG CONJUGATES
- Publication number 20170151341
- Publication date Jun 1, 2017
- Pfizer Inc.
- Dangshe MA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-IL-13 RECEPTOR ALPHA 2 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
- Publication number 20150266962
- Publication date Sep 24, 2015
- Pfizer Inc.
- Dangshe Ma
- G01 - MEASURING TESTING
Information Patent Application
PSMA ANTIBODIES AND USES THEREOF
- Publication number 20150197577
- Publication date Jul 16, 2015
- PSMA Development Company, LLC
- Paul J. Maddon
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODIES FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE-ASSOCIATED IN...
- Publication number 20150175681
- Publication date Jun 25, 2015
- Progenics Pharmaceuticals, Inc.
- Dangshe Ma
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PSMA ANTIBODIES AND USES THEREOF
- Publication number 20140286859
- Publication date Sep 25, 2014
- PSMA Development Company, LLC
- Paul J. Maddon
- G01 - MEASURING TESTING
Information Patent Application
Alpha Emitting Constructs and Uses Thereof
- Publication number 20130295008
- Publication date Nov 7, 2013
- David A. Scheinberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE-ASSOCIATED IN...
- Publication number 20130202618
- Publication date Aug 8, 2013
- Progenics Pharmaceuticals, Inc.
- Dangshe Ma
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR KILLING PSMA-EXPRESSING, TAXANE-RESISTANT CANCER CELLS
- Publication number 20110250216
- Publication date Oct 13, 2011
- PSMA Development Company, LLC
- Dangshe Ma
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Alpha-Emitting constructs and uses thereof
- Publication number 20100278727
- Publication date Nov 4, 2010
- David A. Scheinberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions of PSMA antibodies
- Publication number 20080286284
- Publication date Nov 20, 2008
- PSMA Development Company, LLC
- Paul J. Maddon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PSMA antibody-drug conjugates
- Publication number 20070160617
- Publication date Jul 12, 2007
- PSMA Development Company, LLC
- Dangshe Ma
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PSMA formulations and uses thereof
- Publication number 20040161776
- Publication date Aug 19, 2004
- Paul J. Maddon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-cd19 immunotoxins
- Publication number 20040136908
- Publication date Jul 15, 2004
- William C. Olson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PSMA antibodies and protein multimers
- Publication number 20040033229
- Publication date Feb 19, 2004
- Paul J. Maddon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Anti-CD8 antibodies and uses thereof

Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging

Radiolabeled MET binding proteins for immuno-PET imaging and method...

Anti-CD8 antibodies and uses thereof

Radiolabeled anti-LAG3 antibodies for immuno-PET imaging

Radiolabeled anti-LAG3 antibodies for immuno-PET imaging

Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging

Anti-CD8 antibodies and uses thereof

Site specific HER2 antibody drug conjugates

Anti-IL-13 receptor alpha 2 antibodies and antibody-drug conjugates

PSMA antibodies and uses thereof

Alpha emitting constructs and uses thereof

Methods for killing PSMA-expressing, taxane-resistant cancer cells

Antibodies for the treatment of Clostridium difficile-associated in...

Alpha-emitting constructs and uses thereof

PSMA antibodies and uses thereof

Compositions of PSMA antibodies

PSMA antibodies and protein multimers

Alpha emitting constructs and uses thereof

Targeted alpha particle therapy using actinium-255 conjugates

Bismuth-213 generator and uses thereof

Patents Applicationslast 30 patents

RADIOLABELED ANTI-PD-L1 ANTIBODIES FOR IMMUNO-PET IMAGING

RADIOLABELED MET BINDING PROTEINS FOR IMMUNO-PET IMAGING

RADIOLABELED ANTI-LAG3 ANTIBODIES FOR IMMUNO-PET IMAGING

ANTI-CD8 ANTIBODIES AND USES THEREOF

RADIOLABELED ANTI-PD-L1 ANTIBODIES FOR IMMUNO-PET IMAGING

ANTI-CD8 ANTIBODIES AND USES THEREOF

RADIOLABELED ANTI-LAG3 ANTIBODIES FOR IMMUNO-PET IMAGING

RADIOLABELED MET BINDING PROTEINS FOR IMMUNO-PET IMAGING

PSMA ANTIBODY-DRUG CONJUGATES

SITE SPECIFIC HER2 ANTIBODY DRUG CONJUGATES

RADIOLABELED ANTI-PD-L1 ANTIBODIES FOR IMMUNO-PET IMAGING

ANTIBODIES AND ANTIBODY FRAGMENTS FOR SITE-SPECIFIC CONJUGATION

ANTI-CD8 ANTIBODIES AND USES THEREOF

RADIOLABELED ANTI-LAG3 ANTIBODIES FOR IMMUNO-PET IMAGING

RADIOLABELED ANTI-PD-L1 ANTIBODIES FOR IMMUNO-PET IMAGING

ANTIBODIES AND ANTIBODY FRAGMENTS FOR SITE-SPECIFIC CONJUGATION

SITE SPECIFIC HER2 ANTIBODY DRUG CONJUGATES

ANTI-IL-13 RECEPTOR ALPHA 2 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

PSMA ANTIBODIES AND USES THEREOF

ANTIBODIES FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE-ASSOCIATED IN...

PSMA ANTIBODIES AND USES THEREOF

Alpha Emitting Constructs and Uses Thereof

ANTIBODIES FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE-ASSOCIATED IN...

METHODS FOR KILLING PSMA-EXPRESSING, TAXANE-RESISTANT CANCER CELLS

Alpha-Emitting constructs and uses thereof

Compositions of PSMA antibodies

PSMA antibody-drug conjugates

PSMA formulations and uses thereof

Anti-cd19 immunotoxins

PSMA antibodies and protein multimers